81 related articles for article (PubMed ID: 26169693)
1. miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression.
Yu P; Wu D; You Y; Sun J; Lu L; Tan J; Bie P
Exp Cell Res; 2015 Aug; 336(2):232-41. PubMed ID: 26169693
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression.
Chen JQ; Ou YL; Huang ZP; Hong YG; Tao YP; Wang ZG; Ni JS; Hao LQ; Lin H
Sci Rep; 2019 Jul; 9(1):9820. PubMed ID: 31285444
[TBL] [Abstract][Full Text] [Related]
3. miR-124-3p combined with miR-506-3p delay hepatic carcinogenesis via modulating sirtuin 1.
Xiang H; Luo M; Hou P; Xiao Z; Huang Z; Feng Q; Zhang R; Li Y; Wu L
Biomarkers; 2021 May; 26(3):196-206. PubMed ID: 33401967
[TBL] [Abstract][Full Text] [Related]
4. miR‑29b suppresses proliferation and induces apoptosis of hepatocellular carcinoma ascites H22 cells via regulating TGF‑β1 and p53 signaling pathway.
Liu YL; Yang WH; Chen BY; Nie J; Su ZR; Zheng JN; Gong ST; Chen JN; Jiang D; Li Y
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34184070
[TBL] [Abstract][Full Text] [Related]
5. miR-590-3p and Its Downstream Target Genes in HCC Cell Lines.
Elfar M; Amleh A
Anal Cell Pathol (Amst); 2019; 2019():3234812. PubMed ID: 31781476
[TBL] [Abstract][Full Text] [Related]
6. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
Moreno T; Monterde B; González-Silva L; Betancor-Fernández I; Revilla C; Agraz-Doblas A; Freire J; Isidro P; Quevedo L; Blanco R; Montes-Moreno S; Cereceda L; Astudillo A; Casar B; Crespo P; Morales Torres C; Scaffidi P; Gómez-Román J; Salido E; Varela I
Oncogene; 2021 Apr; 40(16):2923-2935. PubMed ID: 33742126
[TBL] [Abstract][Full Text] [Related]
7. Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.
Bruno T; Catena V; Corleone G; Cortile C; Cappelletto MC; Bellei B; De Nicola F; Amadio B; Gumenyuk S; Marchesi F; Annibali O; Blandino G; Fanciulli M; Di Agostino S
Leukemia; 2024 Apr; 38(4):877-882. PubMed ID: 38368441
[No Abstract] [Full Text] [Related]
8. ARID2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implications.
You J; Yang H; Lai Y; Simon L; Au J; Burkart AL
Hum Pathol; 2015 Jul; 46(7):1068-77. PubMed ID: 26284269
[TBL] [Abstract][Full Text] [Related]
9. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Lee JJ; Sholl LM; Lindeman NI; Granter SR; Laga AC; Shivdasani P; Chin G; Luke JJ; Ott PA; Hodi FS; Mihm MC; Lin JY; Werchniak AE; Haynes HA; Bailey N; Liu R; Murphy GF; Lian CG
Clin Epigenetics; 2015; 7(1):59. PubMed ID: 26221190
[TBL] [Abstract][Full Text] [Related]
10. CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology.
Yang M; Li T; Guo S; Song K; Gong C; Huang N; Pang D; Xiao H
J Transl Med; 2024 Jan; 22(1):50. PubMed ID: 38216965
[TBL] [Abstract][Full Text] [Related]
11. Expression Signature of the AT-Rich Interactive Domain Gene Family Identified in Digestive Cancer.
Lu Y; Liu Z; Wang W; Chen X; Zhou X; Fu W
Front Med (Lausanne); 2021; 8():775357. PubMed ID: 35127746
[TBL] [Abstract][Full Text] [Related]
12.
Liu X; Zhang H; Zhou P; Yu Y; Zhang H; Chen L; Gong J; Liu Z
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786634
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of miR-208a Exacerbates CCl
Bala S; Calenda CD; Catalano D; Babuta M; Kodys K; Nasser IA; Vidal B; Szabo G
Hepatol Commun; 2020 Oct; 4(10):1487-1501. PubMed ID: 33024918
[TBL] [Abstract][Full Text] [Related]
14. ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
Loesch R; Chenane L; Colnot S
Cells; 2020 Sep; 9(10):. PubMed ID: 32977645
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑208a directly targets Src kinase signaling inhibitor 1 to facilitate cell proliferation and invasion in non‑small cell lung cancer.
Liu L; Wang W; Gao S; Wang X
Mol Med Rep; 2019 Oct; 20(4):3140-3148. PubMed ID: 31432113
[TBL] [Abstract][Full Text] [Related]
16. MiR-208a-3p functions as an oncogene in colorectal cancer by targeting PDCD4.
Wu H; Xu L; Chen Y; Xu C
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30914452
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2.
Wang Y; Chang W; Chang W; Chang X; Zhai S; Pan G; Dang S
J Cancer; 2018; 9(22):4187-4196. PubMed ID: 30519319
[TBL] [Abstract][Full Text] [Related]
18. miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1.
Arfat Y; Basra MAR; Shahzad M; Majeed K; Mahmood N; Munir H
Mol Ther Nucleic Acids; 2018 Jun; 11():323-336. PubMed ID: 29858067
[TBL] [Abstract][Full Text] [Related]
19. HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.
Gao Q; Wang K; Chen K; Liang L; Zheng Y; Zhang Y; Xiang J; Tang N
Cancer Sci; 2017 Jul; 108(7):1328-1337. PubMed ID: 28498550
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
